Possibia

4664738

Last Update Posted: 2023-09-08

Recruiting has ended

All Genders

accepted

18 Years-75 Years

8 Estimated Participants

No Expanded Access

Interventional Study

Does not accept healthy volunteers

PEP on a Skin Graft Donor Site Wound

The purpose of this study is to determine the safety of a biological therapeutic PEP in participants who have skin graft donor site wounds.

This is an open label phase 1b study of PEP (a leukocyte depleted blood preparation derived from human U.S. sourced pooled apheresed platelets) in patients with at least two donor split-thickness skin graft wounds. One donor site will be treated with the standard post-operative dressing, while the other site will be treated with PEP or PEP+TISSEEL and covered with a standard dressing. TISSEEL is a commercially available fibrin sealant.

Eligibility

Relevant conditions:

Skin Graft

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov